BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 18377367)

  • 21. Infants hospitalised with pertussis: estimating the true disease burden.
    Somerville RL; Grant CC; Grimwood K; Murdoch D; Graham D; Jackson P; Meates-Dennis M; Nicholson R; Purvis D
    J Paediatr Child Health; 2007 Sep; 43(9):617-22. PubMed ID: 17608654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications?
    Takeuchi M; Yasunaga H; Horiguchi H; Matsuda S
    Epidemiol Infect; 2012 Aug; 140(8):1497-502. PubMed ID: 22008091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
    Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
    Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential impact of acceleration of the pertussis vaccine primary series for infants.
    Shinall MC; Peters TR; Zhu Y; Chen Q; Poehling KA
    Pediatrics; 2008 Nov; 122(5):1021-6. PubMed ID: 18977982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Action to be taken when facing one or more cases of whooping-cough].
    Floret D; Bonmarin I; Deutsch P; Gaudelus J; Grimprel E; Guérin N; Guiso N; Morer I
    Arch Pediatr; 2005 Aug; 12(8):1281-91. PubMed ID: 15961299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for the administration of acellular pertussis vaccine to parents of infants in the neonatal intensive care unit.
    Shah S; Caprio M; Mally P; Hendricks-Munoz K
    J Perinatol; 2007 Jan; 27(1):1-3. PubMed ID: 17180125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of an accelerated immunisation schedule on pertussis in England and Wales.
    White JM; Fairley CK; Owen D; Matthews RC; Miller E
    Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of pre-school booster vaccination of 4--6-year-old children on pertussis in 0--1-year-old children.
    Hviid A; Stellfeld M; Wohlfahrt J; Andersen PH; Melbye M
    Vaccine; 2006 Feb; 24(9):1401-7. PubMed ID: 16207504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
    de Greeff SC; de Melker HE; Westerhof A; Schellekens JF; Mooi FR; van Boven M
    Epidemiology; 2012 Nov; 23(6):852-60. PubMed ID: 23018969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis vaccine--time to stop the confusion.
    Burgess MA
    Med J Aust; 1994 Sep; 161(5):293-4. PubMed ID: 7830662
    [No Abstract]   [Full Text] [Related]  

  • 32. Pertussis control in the Asia-Pacific region: a report from the Global Pertussis Initiative.
    Forsyth K; Thisyakorn U; von König CH; Tan T; Plotkin S;
    Southeast Asian J Trop Med Public Health; 2012 May; 43(3):699-711. PubMed ID: 23077850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pertussis vaccine in adolescents and adults].
    Lévy J; Swennen B; Van Laethem Y
    Rev Med Brux; 2004 Sep; 25(4):A229-32. PubMed ID: 15516047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adolescent and adult pertussis vaccination: computer simulations of five new strategies.
    Van Rie A; Hethcote HW
    Vaccine; 2004 Aug; 22(23-24):3154-65. PubMed ID: 15297068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies.
    de Greeff SC; Lugnér AK; van den Heuvel DM; Mooi FR; de Melker HE
    Vaccine; 2009 Mar; 27(13):1932-7. PubMed ID: 19368774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
    Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
    Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pertussis hospitalizations among infants in the United States, 1993 to 2004.
    Cortese MM; Baughman AL; Zhang R; Srivastava PU; Wallace GS
    Pediatrics; 2008 Mar; 121(3):484-92. PubMed ID: 18310196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in australia.
    Foxwell AR; McIntyre P; Quinn H; Roper K; Clements MS
    Pediatr Infect Dis J; 2011 Feb; 30(2):161-3. PubMed ID: 20811313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pertussis notifications in Australia, 1991 to 1997.
    Andrews R; Herceg A; Roberts C
    Commun Dis Intell; 1997 May; 21(11):145-8. PubMed ID: 9188218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of pertussis in England and Wales.
    Miller E; Vurdien JE; White JM
    Commun Dis Rep CDR Rev; 1992 Dec; 2(13):R152-4. PubMed ID: 1285134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.